Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.LANA.2025.101019 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacterales (CRE) impose the greatest burden among critical bacterial pathogens. Evidence for sex differences among antibiotic resistant bacterial infections is increasing but a focus on policy implications is needed. We assessed impact of CRE/MRSA on excess length of hospital stay, intensive care unit admission, and mortality by sex from a retrospective cohort study (n = 873) of patients in three Chilean hospitals, 2018-2021. Methods We used inverse-probability weighting combined with descriptive, logistic, and competing-risks analyses. We developed a sex-stratified deterministic compartmental model to analyse hospital transmission dynamics and the cost-effectiveness of nine interventions. We compared interventions based on the incremental costeffectiveness ratio (ICER) per quality-adjusted life year (QALY) gained and estimated net benefits. Findings The adjusted odds of women acquiring CRE and MRSA were 0.44 (0.28-0.70; p = 0.0013) and 0.73 (95% CI = 0.48-1.01; p = 0.050), respectively. Competing-risk models indicated higher mortality rates among women, compared to men. Mathematical model projections showed that pre-emptive isolation across all newly admitted high-risk men was the most cost-effective intervention (ICER = $1366/QALY and $1083/QALY for CRE and MRSA, respectively). Chromogenic agar coupled with MRSA decolonisation was the second most cost-effective intervention ($2099/QALY), followed by screening plus isolation or pre-emptive isolation strategies (ICER ranged between $2411/QALY and $4216/QALY across CRE and MRSA models). Probabilistic sensitivity analysis showed that strategies were ICER < willingness-to-pay in 80% of simulations, except for testing plus digestive decolonisation for CRE. At a 20% national hospital coverage at least $12.2 million could be saved. Interpretation Our model suggests that targeted infection control strategies would effectively address rising CRE and MRSA infections. Maximising health-economic gains may be achieved by focusing on control measures for men as primary drivers for transmission, thereby reducing the disproportionate disease burden borne by women. Copyright (c) 2025 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Allel, Kasim | Hombre |
UNIV OXFORD - Reino Unido
Pontificia Universidad Católica de Chile - Chile London Sch Hyg & Trop Med - Reino Unido University of Oxford Medical Sciences Division - Reino Unido London School of Hygiene & Tropical Medicine - Reino Unido London School of Hygiene & Tropical Medicine - Reino Unido |
| 2 | Garcia, Patricia | - |
Pontificia Universidad Católica de Chile - Chile
|
| 3 | Peters, Anne | Mujer |
Universidad del Desarrollo - Chile
|
| 4 | MUNITA-SEPULVEDA, JOSE MANUEL | Hombre |
Universidad del Desarrollo - Chile
|
| 5 | Undurraga, Eduardo A. | - |
Pontificia Universidad Católica de Chile - Chile
Centro de Investigación para la Gestión Integrada del Riesgo de Desastres (CIGIDEN) - Chile |
| 6 | Yakob, Laith | - |
London Sch Hyg & Trop Med - Reino Unido
London School of Hygiene & Tropical Medicine - Reino Unido London School of Hygiene & Tropical Medicine - Reino Unido |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias |
| ANID Fondecyt |
| Agencia Nacional de Investigación y Desarrollo |
| Agencia Nacional de Investigacion y Desarrollo ANID, Chile |
| Beca de Doctorado en el Extranjero |
| Royal Society of Tropical Medicine and Hygiene |
| Agradecimiento |
|---|
| Agencia Nacional de Investigacion y Desarrollo ANID, Chile. |
| Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID, Chile.We thank the Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID through the Fondo Nacional de Desarrollo Cient\u00EDfico y Tecnol\u00F3gico FONDECYT Grants 1211933 (to PG, JM, EU), Beca de Doctorado en el Extranjero Becas Chile 2020 Grant 72210084 (to KA), and Royal Society of Tropical Medicine and Hygiene (RSTMH) for its support through the 2021 early career grant award (KA). We also thank ANID FONDECYT and FONDAP (Grant numbers: 1242022 and 1522A0005 to EU). |
| Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID, Chile.We thank the Agencia Nacional de Investigaci\u00F3n y Desarrollo ANID through the Fondo Nacional de Desarrollo Cient\u00EDfico y Tecnol\u00F3gico FONDECYT Grants 1211933 (to PG, JM, EU), Beca de Doctorado en el Extranjero Becas Chile 2020 Grant 72210084 (to KA), and Royal Society of Tropical Medicine and Hygiene (RSTMH) for its support through the 2021 early career grant award (KA). We also thank ANID FONDECYT and FONDAP (Grant numbers: 1242022 and 1522A0005 to EU). |